|Dr. Liangzhi Xie Ph.D.||Founder, Pres & Chairman||N/A||N/A||1966|
|Mr. Zhang Jie Ph.D.||Gen. Mang.||N/A||N/A||N/A|
Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, and other reagents that are used in the areas of cancer, cardiovascular biology, cell and developmental biology, epigenetics, immunology, neuroscience, signal transduction, and stem cells. The company also provides pre-clinical production technology services for monoclonal antibody drug candidates; and custom services, such as protein expression, custom antibody production, and biological analysis and testing services. It serves academic research institutions, biotech companies, and pharmaceutical companies. The company was founded in 2016 and is headquartered in Beijing, China.
Sino Biological,Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.